Hui Sheng Bio-pharmaceutical Co.

BiotechnologySeries AMeihekou, Chinahuishengpharm.com

Latest round

Series A

Last raised

Jan 2023

Total raised

$159M

Investors

7

About Hui Sheng Bio-pharmaceutical Co.

Ltd. operates as a biopharmaceutical company specializing in the field of diabetes and complications treatment. As of 2022, it has more than 4,000 employees. The company's product pipelines can be categorized into insulin and its analogues, GLP-1 analogues, biguanides, DPP-4 inhibitors, SGLT-2 inhibitors, glinides, and complications. It has more than 40 types of diabetes and complications product pipelines.

Who invested in Hui Sheng Bio-pharmaceutical Co.

7 investors across 2 rounds

See all investors in Hui Sheng Bio-pharmaceutical Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jan 4, 2023

    Amount

    $85M

    Investors

    Locked

  2. Series A

    Jun 1, 2022

    Amount

    $75M

    Investors

    Locked

Questions about Hui Sheng Bio-pharmaceutical Co.

Who invested in Hui Sheng Bio-pharmaceutical Co.?

Hui Sheng Bio-pharmaceutical Co. has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Hui Sheng Bio-pharmaceutical Co. raised?

Hui Sheng Bio-pharmaceutical Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Hui Sheng Bio-pharmaceutical Co. last raise money?

Hui Sheng Bio-pharmaceutical Co.'s most recent round on record is a Series A, in Jan 2023.

What does Hui Sheng Bio-pharmaceutical Co. do?

Hui Sheng Bio-pharmaceutical Co. is a biotechnology company.

Where is Hui Sheng Bio-pharmaceutical Co. headquartered?

Hui Sheng Bio-pharmaceutical Co. is headquartered in Meihekou, China.

Which VCs invest in companies like Hui Sheng Bio-pharmaceutical Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Hui Sheng Bio-pharmaceutical Co.'s stage. Their profiles are linked below.

Raising like Hui Sheng Bio-pharmaceutical Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.